S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
NASDAQ:SIBN

SI-BONE (SIBN) Stock Forecast, Price & News

$20.78
-0.41 (-1.93%)
(As of 10/3/2023 ET)
Compare
Today's Range
$20.69
$21.35
50-Day Range
$20.22
$25.76
52-Week Range
$11.14
$29.51
Volume
280,515 shs
Average Volume
308,079 shs
Market Capitalization
$803.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$28.00

SI-BONE MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
34.7% Upside
$28.00 Price Target
Short Interest
Healthy
2.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.44
Upright™ Environmental Score
News Sentiment
0.95mentions of SI-BONE in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$2.02 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.25) to ($0.93) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

454th out of 966 stocks

Surgical & Medical Instruments Industry

54th out of 98 stocks


SIBN stock logo

About SI-BONE (NASDAQ:SIBN) Stock

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and distributors. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

SIBN Price History

SIBN Stock News Headlines

Has SiBone (SIBN) Outpaced Other Medical Stocks This Year?
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Top Analyst Exposes Imminent Crisis Hurtling Towards America
The man who warned of the dot-com blow up, the 2008 housing collapse, and the loss of America’s AAA rating makes a shocking prediction…
Truist Financial Sticks to Their Buy Rating for SI-Bone (SIBN)
Si-bone (NASDAQ: SIBN)
Why Shares of Si-Bone Jumped Tuesday
See More Headlines
Receive SIBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter.

SIBN Company Calendar

Last Earnings
8/07/2023
Today
10/03/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SIBN
Fax
N/A
Employees
357
Year Founded
2008

Price Target and Rating

Average Stock Price Forecast
$28.00
High Stock Price Forecast
$33.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+34.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-61,260,000.00
Pretax Margin
-38.32%

Debt

Sales & Book Value

Annual Sales
$106.41 million
Book Value
$2.85 per share

Miscellaneous

Free Float
36,597,000
Market Cap
$803.98 million
Optionable
Not Optionable
Beta
0.96

Social Links

The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Ms. Laura A. Francis MBA (Age 56)
    CEO & Director
    Comp: $1.11M
  • Mr. Anshul Maheshwari (Age 43)
    Chief Financial Officer
    Comp: $614.25k
  • Mr. Anthony J. RecuperoMr. Anthony J. Recupero (Age 64)
    Pres of Commercial Operations
    Comp: $795.32k
  • Mr. Jeff Bertolini
    Sr. VP of Operations & Information Technology
  • Dr. Scott A. Yerby (Age 55)
    Sr. VP of Engineering & CTO
  • Mr. Michael A. PisetskyMr. Michael A. Pisetsky (Age 45)
    Chief Bus. & Legal Affairs Officer
  • Ms. Aimee Einstein
    VP of People & Culture
  • Dr. Daniel Joseph Cher (Age 58)
    Sr. VP of Clinical & Regulatory Affairs
  • Dr. W. Carlton Reckling (Age 61)
    Chief Medical Officer & VP of Medical Affairs
  • Mr. Nikolas F. Kerr (Age 51)
    Sr. VP of Product, Strategy & Bus. Devel.













SIBN Stock - Frequently Asked Questions

Should I buy or sell SI-BONE stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SI-BONE in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SIBN shares.
View SIBN analyst ratings
or view top-rated stocks.

What is SI-BONE's stock price forecast for 2023?

7 Wall Street research analysts have issued 1-year price targets for SI-BONE's stock. Their SIBN share price forecasts range from $20.00 to $33.00. On average, they anticipate the company's share price to reach $28.00 in the next twelve months. This suggests a possible upside of 34.7% from the stock's current price.
View analysts price targets for SIBN
or view top-rated stocks among Wall Street analysts.

How have SIBN shares performed in 2023?

SI-BONE's stock was trading at $13.60 at the beginning of 2023. Since then, SIBN stock has increased by 52.8% and is now trading at $20.78.
View the best growth stocks for 2023 here
.

When is SI-BONE's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our SIBN earnings forecast
.

How were SI-BONE's earnings last quarter?

SI-BONE, Inc. (NASDAQ:SIBN) released its quarterly earnings results on Monday, August, 7th. The company reported ($0.30) earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.11. The company had revenue of $33.31 million for the quarter, compared to analyst estimates of $32.24 million. SI-BONE had a negative trailing twelve-month return on equity of 40.35% and a negative net margin of 38.32%.

What guidance has SI-BONE issued on next quarter's earnings?

SI-BONE updated its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $132.00 million-$134.00 million, compared to the consensus revenue estimate of $130.03 million.

What is Jeffrey Dunn's approval rating as SI-BONE's CEO?

10 employees have rated SI-BONE Chief Executive Officer Jeffrey Dunn on Glassdoor.com. Jeffrey Dunn has an approval rating of 41% among the company's employees. This puts Jeffrey Dunn in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of SI-BONE own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-BONE investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), RTX (RTX), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Alibaba Group (BABA), Cisco Systems (CSCO) and CSX (CSX).

When did SI-BONE IPO?

(SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is SI-BONE's stock symbol?

SI-BONE trades on the NASDAQ under the ticker symbol "SIBN."

How do I buy shares of SI-BONE?

Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SI-BONE's stock price today?

One share of SIBN stock can currently be purchased for approximately $20.78.

How much money does SI-BONE make?

SI-BONE (NASDAQ:SIBN) has a market capitalization of $803.98 million and generates $106.41 million in revenue each year. The company earns $-61,260,000.00 in net income (profit) each year or ($1.35) on an earnings per share basis.

How many employees does SI-BONE have?

The company employs 357 workers across the globe.

Does SI-BONE have any subsidiaries?
The following companies are subsidiares of SI-BONE: SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD.
Read More
How can I contact SI-BONE?

SI-BONE's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The official website for the company is www.si-bone.com. The company can be reached via phone at (408) 207-0700 or via email at investors@si-bone.com.

This page (NASDAQ:SIBN) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -